cells

human megakaryocytic cell line, established from the blood of a patient with megakaryoblastic leukemia

Cell Type:

Blood/Bone Marrow SC

Tissue Origin:

blood

Species:

human

Research Area:

Cancer Research/Cell Biology

Immunotherapy / Hematology

Cell Characteristics:

Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline

Filter:

The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.

Protocol	Kit	Program	Cells	Efficiency	Viable Cells	Substrate		Format	Platform
	C	X-005	1e6	35-40%	90%	Plasmid (general)	1 µg	100 µl	I/II/2b
	C	X-005	1e6	40-50%	85%	Plasmid (general)	1 µg	100 µl	I/II/2b

Dami

Transfection Information